Since TAMs could be re-programmed to induce anti-tumor responses, infiltration of CD8+ T cells and the presence of TAMs in the tumor microenvironment is mandatory for successful immunotherapy [1,63,64,65]. This evidence concerns the gene CD8A and neoplasm.